Cargando…
Adjuvant Treatment for Breast Cancer Patients Using Individualized Neoantigen Peptide Vaccination—A Retrospective Observation
Breast cancer is a tumor entity that is one of the leading causes of mortality among women worldwide. Although numerous treatment options are available, current explorations of personalized vaccines have shown potential as promising new treatment options to prevent the recurrence of cancer. Here we...
Autores principales: | Zelba, Henning, McQueeney, Alex, Rabsteyn, Armin, Bartsch, Oliver, Kyzirakos, Christina, Kayser, Simone, Harter, Johannes, Latzer, Pauline, Hadaschik, Dirk, Battke, Florian, Hartkopf, Andreas D., Biskup, Saskia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698403/ https://www.ncbi.nlm.nih.gov/pubmed/36366390 http://dx.doi.org/10.3390/vaccines10111882 |
Ejemplares similares
-
Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer
por: Zelba, Henning, et al.
Publicado: (2023) -
Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report
por: Blumendeller, Carolin, et al.
Publicado: (2021) -
The IBM Research Global Technology Outlook
por: McQueeney, Dave
Publicado: (2004) -
Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas
por: Hickmann, Anne-Katrin, et al.
Publicado: (2019) -
Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors – Results of a Prospective Biomarker Study
por: Forschner, Andrea, et al.
Publicado: (2020)